Analyzing genomic data from more than 1 million people, researchers have identified genes that are commonly inherited across substance use disorders, regardless of the substance being used.
In recognition of World Bipolar Day, NIMH is conducting a Facebook Live on bipolar disorder in adults.
Researchers investigated whether home delivery of ART for a modest fee could help improve ART access and use, finding it resulted in increased viral suppression in participants compared with clinic-based medication distribution.
During this lecture, Sharon L. Walsh, Ph.D., discussed how the HEALing Communities Study (HCS) is testing the prevention and treatment of opioid misuse in select communities hard hit by the opioid crisis.
A long-acting antiretroviral treatment given every four to eight weeks, and delivered with comprehensive support services, suppressed HIV in people who were previously not virologically suppressed.
An NIMH-supported study shows that preference for geometric images may be robust enough to serve as a biomarker for identifying some young children with autism.
This concept aims to encourage research that will enhance knowledge of mechanisms underlying neuropsychiatric symptoms (NPS) in dementia, leading to the development of novel treatments.
The goal of this concept is to examine mechanisms of reciprocal interactions between HIV-associated neuroinflammation and central nervous system (CNS) persistence in the setting of excellent virologic control using novel CNS cell systems, organoid models, and single-cell technologies.
This meeting highlighted health economics research supported by the National Institute of Mental Health (NIMH) and the National Institute on Drug Abuse (NIDA).
Karen Berman, M.D., a senior investigator at the National Institute of Mental Health (NIMH), has been elected as a 2022 American Association for the Advancement of Science (AAAS) Fellow.